Abstract
Cervical cancer is the second leading cause of cancer death for women in the Dominican Republic. Pap smear screening in the Dominican Republic has not achieved adequate reduction in cervical cancer mortality. The purpose of this study was to examine Dominican provider practices for cervical cancer screening and the use of national or international screening guidelines. We surveyed 101 gynecology specialists, 50 non-specialists, and 51 obstetrics-gynecology residents in the Santo Domingo and Monte Plata provinces of the Dominican Republic regarding their cervical cancer screening practices and use of guidelines. Bivariate (chi-square) analyses were conducted to compare screening practices by demographic and practice characteristics. The majority of providers followed WHO guidelines (62.9%) and/or Dominican national norms (59.4%). The majority (87%) of providers use time since first sexual activity as the basis for screening initiation; 96% advise screening every 6–12 months. The most commonly used screening test is the conventional Pap smear. Colposcopy was recommended most often for all abnormal Pap results. Dominican providers report they follow national and/or international cervical cancer screening guidelines. They do not follow age-based screening guidelines, nor have they adopted an extended interval for screening and continue to recommend screening at least annually. A culture of early and frequent screening has consequences in terms of cost, high demand for follow-up services, and reduced capacity to reach the populations at highest risk. Early screening also may challenge the acceptability of adopting alternative screening technologies such as HPV testing.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Bruni L et al., “Dominican Republic: human papillomavirus and related diseases, Summary Report 2015 - DOM.pdf,” 23-Dec-2015. [Online]. Available: http://hpvcentre.net/statistics/reports/DOM.pdf. [Accessed: 31-Mar-2016]
World Health Organization (2014) “WHO | Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention,” WHO. [Online]. Available: http://apps.who.int/rhl/guidelines/screening_and_treatment_of_precancerous_lesions/en/. [Accessed: 30-May-2016]
Ministry of Health, Dominican Republic (2007) “Salud y Sociedad Civil,” Normas de Prevencion, Diagnostico Temprano y Tratamiento de Cancer Cervicouterino. [Online]. Available: http://saludysociedadcivil.org.do/index.php. [Accessed: 22-Sep-2017]
Saslow D et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 62(3):147–172
ENDESA (2013) “República Dominicana Encuesta Demográfica y de Salud 2013 [FR292] - FR292.pdf,”. [Online]. Available: http://dhsprogram.com/pubs/pdf/FR292/FR292.pdf. [Accessed: 31-Mar-2016]
Jeronimo J et al (2016) Secondary prevention of cervical cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol:JGO006577
Liebermann EJ et al (2019) Barriers to Cervical cancer screening and treatment in the Dominican Republic: perspectives of focus group participants in the Santo Domingo Area. J Transcult Nurs:104365961984624
“Centros de Salud de la República Dominicana - Portal de Datos Abiertos de la RD.” [Online]. Available: https://datos.gob.do/dataset/listado-de-centros-de-salud. [Accessed: 23-May-2019]
Stormo AR et al (2012) Bolivian health providers’ attitudes toward alternative technologies for cervical cancer prevention: a focus on visual inspection with acetic acid and cryotherapy. J Womens Health 2002 21(8):801–808
Townsend J, Stormo A, Roland K, Buenconsejo-Lum L, White S, Saraiya M (2014) Current cervical cancer screening knowledge, awareness, and practices among US affiliated Pacific Island providers: opportunities and challenges. ONCOLOGIST 19(4):383–393
Hilton A, Skrutkowski M (2002) Translating instruments into other languages: development and testing processes. Cancer Nurs 25(1):1–7
Maneesriwongul W, Dixon JK (2004) Instrument translation process: a methods review. J Adv Nurs 48(2):175–186
Nayar R, Wilbur D (eds) (2015) The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes, 3rd edn. Springer International Publishing
Stormo AR, de Moura L, Saraiya M (2014) Cervical cancer-related knowledge, attitudes, and practices of health professionals working in Brazil’s network of primary care units. Oncologist 19(4):375–382
Ogilvie G, Nakisige C, Huh WK, Mehrotra R, Franco EL, Jeronimo J (2017) Optimizing secondary prevention of cervical cancer: recent advances and future challenges. Int J Gynecol Obstet 138:15–19
Funding
This research was supported in part by the NYU CTSA grant TL1 TR001447 from the National Center for Advancing Translational Sciences, National Institutes of Health. Additional support was received through New York University Rory Meyers College of Nursing Fred Schmidt and Paula Greenidge Scholarships and the Sigma Theta Tau Upsilon Chapter Research Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liebermann, E., Hammer, M.J., Gúzman, N.F. et al. Dominican Provider Practices for Cervical Cancer Screening in Santo Domingo and Monte Plata Provinces. J Canc Educ 36, 693–701 (2021). https://doi.org/10.1007/s13187-020-01690-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-020-01690-9